VRDN — Viridian Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Viridian Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	26.8	128	197	425	477
Net Total Accounts Receivable
Net Total Receivables	0.108	—	0.451	0.102	0.102
Prepaid Expenses
Total Current Assets	29.7	130	200	431	486
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.523	0.787	2.06	2.94	3.34
Other Long Term Assets
Total Assets	30.3	131	204	435	490
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	10.2	10.7	13.6	33.3	26.6
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	14.5	11.2	16	40	48.4
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	15.8	120	188	395	442
Total Liabilities & Shareholders' Equity	30.3	131	204	435	490
Total Common Shares Outstanding
Total Preferred Shares Outstanding